MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20223402

June 16, 2022

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C₁₆H₂₈N₂O₄计)

化学药品

June 16, 2022

Company Information

Applicant Company

苏州工业园区星湖街218号C25楼、C26楼、C27楼、C28楼

Manufacturing Company

苏州工业园区星湖街218号C25楼、C26楼、C27楼、C28楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath